07.03.26 -- STREAM Edition: Cell Therapy Without The Cells: Building A Therapeutic Secretome With Noveome Biotherapeutics' Larry Brown, Sc.D.

Explore the application of a platform in creating CHO cell lines for manufacturing, emphasizing the uniformity of the pools generated in terms of titer and the rapid selection of these pools.

Once you have developed your antibody, you are in a race to start manufacturing. Discover a method that allows you to accelerate viral detection by combining the broad range of NGS with PCR.

In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Larry Brown, Sc.D., chief scientific officer at Noveome Biotherapeutics, to discuss ST266, a first-of-its-kind secretome therapy.

Maggie Chen, Senior Director, Manufacturing & MSAT, AGC Biologics, shares insight into how the standardization process can help reduce project timelines and overall costs on the path to market.

Gain insight into how new imaging systems offer faster scans, broader assay support, and high-confidence data that is ideal for researchers seeking reproducibility in Western blot workflows.

EU GMP Annex 1 is driving meaningful changes in how teams behave. Understand what contamination awareness really means in practice and how to build a culture where speaking up is standard.